The European Medical Journal Introduces: EMJ 3.4!

LONDON - Dec. 13, 2018 - PRLog -- Detailing a myriad of fascinating topics inside, the multidisciplinary publication, EMJ 3.4, is now available.

Presenting high-quality peer-reviewed articles that are sure to whet the appetite of individuals from across the field of medicine, the latest edition of the European Medical Journal details topics ranging from the diagnosis and treatment of asthma, to the effect of mesenchymal stem cells in autoimmune arthritis.

The Editor's Pick for this edition, by Ayers and Nasta, considers the most recent developments in the immunotherapeutic treatment of non-Hodgkin's lymphoma. Encompassing chimeric antigen receptor T cells, T cell engager antibodies, and immune checkpoint inhibition, this fascinating review highlights the successes and aims to guide future study.

As 2019 rapidly approaches, this publication is sure to push the boundaries of medical science, bringing together fascinating articles providing a springboard for productive discussion within the medical community. (https://www.emjreviews.com/european-medical-journal/journ...)